Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial

Robert J. Lederman, Alan N. Tenaglia, R. David Anderson, James B. Hermiller, Krishna Rocha-Singh, Farrell O. Mendelsohn, William R. Hiatt, Thomas Moon, M. J. Whitehouse, Brian H. Annex

Research output: Contribution to journalArticle

12 Scopus citations
Original languageEnglish (US)
Pages (from-to)192-195
Number of pages4
JournalAmerican Journal of Cardiology
Volume88
Issue number2
DOIs
StatePublished - Jul 15 2001
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lederman, R. J., Tenaglia, A. N., Anderson, R. D., Hermiller, J. B., Rocha-Singh, K., Mendelsohn, F. O., Hiatt, W. R., Moon, T., Whitehouse, M. J., & Annex, B. H. (2001). Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial. American Journal of Cardiology, 88(2), 192-195. https://doi.org/10.1016/S0002-9149(01)01622-8